Recent Quarter Total Invested
$144.12 M
Recent Quarter Institutional Ownership Percentage
59.29%
Total Invested of Last Quarter
$150.03 M
Ownership Percentage of Last Quarter
63.63%
Adaptimmune Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MATRIX CAPITAL MANAGEMENT COMPANY, LP | 11/14/2024 | 37.68 M | $35.81 B | -3.32% | 14.73% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 27.40 M | $26.04 M | 0.00% | 10.71% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 17.08 M | $16.23 M | 0.00% | 6.68% |
| BAILLIE GIFFORD & CO | 11/05/2024 | 16.78 M | $15.94 M | 10.74% | 6.56% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 11/13/2024 | 13.30 M | $12.64 M | 7.72% | 5.20% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 10.00 M | $9.50 M | -4.94% | 3.91% |
| MPM ASSET MANAGEMENT LLC | 11/13/2024 | 5.56 M | $5.28 M | 0.00% | 2.17% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 5.10 M | $4.84 M | 0.00% | 1.99% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 4.65 M | $4.42 M | 0.00% | 1.82% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 2.43 M | $2.31 M | 0.00% | 0.95% |
| MORGAN STANLEY | 11/14/2024 | 1.70 M | $1.61 M | 285.41% | 0.66% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.66 M | $1.57 M | -7.26% | 0.65% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.05 M | $993,674 | 0.80% | 0.41% |
| REDMILE GROUP, LLC | 11/14/2024 | 715,607 | $680,113 | 0.00% | 0.28% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 715,350 | $679,869 | -8.24% | 0.28% |
| MARSHALL WACE, LLP | 11/14/2024 | 522,608 | $496,479 | 260.72% | 0.20% |
| RATHBONES GROUP PLC | 11/13/2024 | 432,818 | $411,350 | 0.00% | 0.17% |
| STATE STREET CORP | 11/14/2024 | 396,792 | $377,111 | 1.51% | 0.16% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 341,064 | $324,147 | 0.00% | 0.13% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 283,626 | $269,558 | 100.00% | 0.11% |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | 10/18/2024 | 255,359 | $242,693 | -3.27% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 189,472 | $180,074 | -21.75% | 0.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 139,801 | $132,866 | 18.57% | 0.05% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 101,008 | $96,000 | 27.47% | 0.04% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 99,662 | $95,000 | 100.00% | 0.04% |
| LPL FINANCIAL LLC | 11/08/2024 | 88,856 | $84,449 | -55.32% | 0.03% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 84,410 | $80,223 | 423.67% | 0.03% |
| CAPTRUST FINANCIAL ADVISORS | 11/14/2024 | 83,041 | $78,922 | 0.00% | 0.03% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 66,821 | $63,507 | 4.95% | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 57,201 | $54,364 | 100.00% | 0.02% |
| BARCLAYS PLC | 11/19/2024 | 50,061 | $48,000 | 0.00% | 0.02% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 48,370 | $45,971 | 42.11% | 0.02% |
| VONTOBEL HOLDING LTD. | 10/16/2024 | 43,000 | $40,867 | 230.77% | 0.02% |
| OPPENHEIMER & CO INC | 11/05/2024 | 36,275 | $34,476 | -7.69% | 0.01% |
| FULLCIRCLE WEALTH LLC | 10/29/2024 | 35,000 | $25,802 | 100.00% | 0.01% |
| INVESCO LTD. | 11/12/2024 | 34,809 | $33,082 | 0.19% | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 32,700 | $31,065 | 179.49% | 0.01% |
| COLUMBIA ADVISORY PARTNERS LLC | 10/18/2024 | 31,420 | $29,862 | 11.87% | 0.01% |
| CSS LLC/IL | 11/14/2024 | 30,702 | $29,179 | 0.00% | 0.01% |
| DLK INVESTMENT MANAGEMENT, LLC | 10/09/2024 | 30,512 | $28,999 | 0.00% | 0.01% |
| SIMON QUICK ADVISORS, LLC | 10/15/2024 | 30,452 | $28,942 | 1.51% | 0.01% |
| JANNEY MONTGOMERY SCOTT LLC | 10/29/2024 | 30,000 | $29,000 | 0.00% | 0.01% |
| CITADEL ADVISORS LLC | 11/14/2024 | 28,100 | $26,706 | -57.93% | 0.01% |
| NEWMAN DIGNAN & SHEERAR, INC. | 11/12/2024 | 27,957 | $20,610 | 100.00% | 0.01% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 27,619 | $26,247 | 0.00% | 0.01% |
| IFG ADVISORY, LLC | 10/30/2024 | 27,500 | $26,136 | 100.00% | 0.01% |
| PROSPERITY WEALTH MANAGEMENT, INC. | 11/14/2024 | 24,620 | $23,399 | -7.51% | 0.01% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 10/24/2024 | 23,000 | $22,000 | 0.00% | 0.01% |
| RHUMBLINE ADVISERS | 11/12/2024 | 19,160 | $18,198 | 14.59% | 0.01% |
| BALLENTINE PARTNERS, LLC | 10/23/2024 | 16,758 | $15,927 | 100.00% | 0.01% |
Adaptimmune Therapeutics plcinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ADAP shares?
During the previous two years, 100 institutional investors and hedge funds held shares of Adaptimmune Therapeutics plc. The most heavily invested institutionals were:
Matrix Capital Management Company, LP: 37.68 M
EcoR1 Capital, LLC: 27.4 M
NEA Management Company, LLC: 17.08 M
BAILLIE GIFFORD & CO: 16.78 M
Long Focus Capital Management, LLC: 13.3 M
PFM Health Sciences, LP: 10 M
-
What percentage of Adaptimmune Therapeutics plc stock is owned by institutional investors?
59.29% of Adaptimmune Therapeutics plc stock is owned by institutional investors.
-
How much institutional buying is happening at ADAP ?
Institutional investors have bought a total of 150.22 M shares in the last 24 months. This purchase volume represents approximately $99.14 M in transactions.